Investment Counsel Company of Nevada’s Cardinal Health CAH Stock Holding History

Investment Counsel Company of Nevada’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.7K	Buy	+24	New	+$4.99K	0.01%	116

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Investment Counsel Company of Nevada's CAH Position: Q2 2026 in Review

Investment Counsel Company of Nevada opened a new position in Cardinal Health (CAH) in Q2 2026: 24 shares worth $5.7K. The stake represents 0.01% of the portfolio and ranks #116 among its holdings.

1,104 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Investment Counsel Company of Nevada held 24 shares of Cardinal Health worth $5.7K as of Q2 2026.
Cardinal Health was a new Investment Counsel Company of Nevada position in Q2 2026.
Cardinal Health made up 0.01% of Investment Counsel Company of Nevada's portfolio in Q2 2026, its #116 holding.
1,104 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Investment Counsel Company of Nevada's 13F filing for Q2 2026, filed 10 Aug 2026.